SABCS 2025 Session Makes Sense of Rapidly Evolving Therapeutic Landscape for Breast Cancer
At the SABCS 2025 View From the Trenches session, experts discussed how new clinical trial results might transform breast...
At the SABCS 2025 View From the Trenches session, experts discussed how new clinical trial results might transform breast...
At SABCS 2025, studies show some patients with early-stage breast cancer can skip steps like SLNB or MRI without...
In clinical trials presented at SABCS, a mobile health tool and acupuncture helped to improve breast cancer survivors' quality...
Amid the debate over menopausal hormone therapy and cancer risk, researchers at SABCS provided some clarity for women with...
Throughout the years, SABCS has shown how tucatinib has progressed into a potential frontline therapy for HER2-positive breast cancer.